# Clinical Prevalence of Equine Coital Exanthema in a Thoroughbred Covering Station in Türkiye (2021–2024)

**Authors:** Yunus Emre Atay, Gencay Ekinci, Ali Erdem Öztürk, Mustafa Cem Timur, Alper Mete, Köksal Altınbay, Fatih Mehmet Derelli, Yaşar Akar, İhsan Keleş

PMC · DOI: 10.1111/rda.70086 · Reproduction in Domestic Animals = Zuchthygiene · 2025-06-09

## TL;DR

This study reports the first molecular diagnosis of Equine Coital Exanthema in Türkiye and finds a low clinical prevalence over four years.

## Contribution

The first molecular confirmation of Equine Coital Exanthema in Türkiye using PCR is reported.

## Key findings

- Six out of 228 clinically suspected horses tested positive for EHV-3 (2.6%).
- No outbreaks of Equine Coital Exanthema occurred at the covering station from 2021 to 2024.
- PCR testing was identified as crucial for ECE control when combined with proper management.

## Abstract

Equine Coital Exanthema (ECE) is an endemic herpesvirus disease primarily affecting the external genitalia and impairing mating activities in horses. Its extremely contagious nature, latency and subclinical features can result in outbreaks and significant economic losses. Transmission occurs primarily through mating activities; therefore, robust biosecurity measures are crucial in breeding facilities. This study aims to determine the clinical prevalence of ECE among horses in a covering station in Türkiye from 2021 to 2024. It also aims to assess the efficacy of routine PCR implementation within ECE's control strategies. A cross‐sectional study design has been employed. Genital swab samples were collected from clinically suspected horses, which were tested for EHV‐3 using real‐time PCR. Animal records, clinical examination data and PCR test results were obtained from horses at the covering station between 2021 and 2024. During the 4 years (2021–2024), 9231 mating activities were carried out, and a total of 228 clinically suspected horses were tested for EHV‐3 using real‐time PCR. Among these 228 horses, 6 horses (2.6%) were confirmed positive for EHV‐3. The primary weakness of this study is the failure to detect subclinical cases with PCR. The absence of follow‐up PCR testing in two clinically infected horses represents a limitation of this study. The molecular diagnosis of ECE was reported for the first time in Türkiye. Clinical ECE cases infrequently transpired over the four‐year period at the covering station. No outbreak transpired during this interval. PCR testing plays a crucial role in disease control when implemented with suitable management methods. Additional global epidemiological investigations on ECE are required.

## Full-text entities

- **Diseases:** ECE (MESH:D005076), infected (MESH:D007239), herpesvirus disease (MESH:D006566)
- **Species:** Equus caballus (domestic horse, species) [taxon 9796], Equid alphaherpesvirus 3 (no rank) [taxon 80341]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12146816/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12146816/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12146816/full.md

---
Source: https://tomesphere.com/paper/PMC12146816